Anti-Invasive and Anti-Angiogenic Effects of Xanthohumol and Its Synthetic Derivatives |
Kim, Jung-Ae
(College of Pharmacy, Yeungnam University)
Kang, You-Ra (College of Pharmacy, Yeungnam University) Thapa, Dinesh (College of Pharmacy, Yeungnam University) Lee, Jong-Suk (College of Pharmacy, Yeungnam University) Park, Min-A (College of Pharmacy, Yeungnam University) Lee, Kyung-Hee (Department of Food and Nutrition, Yeungnam University) Lyoo, Won-Seok (School of Testiles, Yeungnam University) Lee, Yong-Rok (School of Chemical Engineering and Technology, Yeungnam University) |
1 | Plazar, J., Zegura, B., Lah, T. T. and Filipic, M. (2007). Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutat. Res. 632, 1-8. DOI ScienceOn |
2 | Thapa, D., Lee, J. S., Park, S. Y., Bae, Y. H., Bae, S. K., Kwon, J. B., Kim, K. J., Kwak, M. K., Park, Y. J., Choi, H. G. and Kim, J. A. (2008). Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-- dependent manner. J. Pharmacol. Exp. Ther. 327, 353-364. DOI ScienceOn |
3 | Miranda, C. L., Aponso, G. L. M., Stevens, J. F., Deinzer, M. L. and Buhler, D. R. (2000a). Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1x1C7 cells. Cancer Lett. 149, 21-29. DOI ScienceOn |
4 | Miranda, C. L., Stevens, J. F., Helmrich, A., Henderson, M. C., Rodriguez, R. J., Yang, Y. H., Deinzer, M. L., Barnes, D. W. and Buhler, D. R. (1999). Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol. 37, 271-285. DOI ScienceOn |
5 | Park, B. C., Thapa, D., Lee, Y. S., Kwak, M. K., Lee, E. S., Choi, H. G., Yong, C. S. and Kim, J. A. (2007). 1-Furan-2-yl-3- pyridin-2-ylpropenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP. Eur. J. Pharmacol. 567, 193-197. DOI ScienceOn |
6 | Johnson, L. L., Dyer, R. and Hupe, D. J. (1998). Matrix metalloproteinases. Curr. Opin. Chem. Biol. 2, 466-471. DOI ScienceOn |
7 | Lee, Y. R., Li, X., Lee, S. W., Yong, C. S., Hong, M. R. and Lyoo, W. S. (2008). ChemInform abstract: concise total synthesis of biologically interesting prenylated chalcone natural products: 4-O-Methylxanthohumol (VIII), xanthohumol E (XII), and sericone (XIII). Bull. Korean Chem. Soc. 29, 1205-1210. DOI ScienceOn |
8 | Halin, C. and Detmar, M. (2008). Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis. Methods Enzymol. 445, 1-25. DOI ScienceOn |
9 | Henderson, M. C., Miranda, C. L., Stevens, J. F., Deinzer, M. L. and Buhler, D. R. (2000). In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30, 235-251. DOI |
10 | John, A. and Tuszynski, G. (2001). The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7, 14-23. DOI ScienceOn |
11 | Vanhoecke, B., Derycke, L., Van Marck, V., Depypere, H., De Keukeleire, D. and Bracke, M. (2005). Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int. J. Cancer. 117, 889-895. DOI ScienceOn |
12 | Westermarck, J. and Kahari, V. M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792. DOI |
13 | Wittekind, C. and Neid, M. (2005) Cancer invasion and metastasis. Oncology 69, 14-16. DOI ScienceOn |
14 | Woessner, Jr. J. F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154. |
15 | Mannello, F. and Gazzanelli, G. (2001). Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6, 479-482. DOI ScienceOn |
16 | Yang, S. F., Yang, W. E., Kuo, W. H., Chang, H. R., Chu, S. C. and Hsieh, Y. S. (2008). Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch. Oral. Biol. 53, 287-294. DOI ScienceOn |
17 | Park, B. C., Park, S. Y., Lee, J. S., Mousa, S. A., Kim, J. T., Kwak, M. K., Kang, K. W., Lee, E. S., Choi, H. G., Yong, C. S. and Kim, J. A. (2009). The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGFinduced signaling. Vascul. Pharmacol. 50, 123-131. DOI ScienceOn |
18 | Stevens, J. F., Miranda, C. L., Frei, B. and Buhler, D. R. (2003). Inhibition of Peroxynitrite-Mediated LDL Oxidation by Prenylated Flavonoids: The ,-Unsaturated Keto Functionality of 2'-Hydroxychalcones as a Novel Antioxidant Pharmacophore. Chem. Res. Toxicol. 16, 1277-1286. DOI ScienceOn |
19 | Vogel, S., Ohmayer, S., Brunner, G. and Heilmann, J. (2008). Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg. Med. Chem. 16, 4286-4293. DOI ScienceOn |
20 | McCawley, L. J. and Matrisian, L. M. (2000). Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 6, 149-156. DOI ScienceOn |
21 | Barbara, V., Lara, D., Veerle Van, M., Herman, D., Denis De, K. and Marc, B. (2005). Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int. J. Cancer. 117, 889-895. DOI ScienceOn |
22 | Monteghirfo, S., Tosetti, F., Ambrosini, C., Stigliani, S., Pozzi, S., Frassoni, F., Fassina, G., Soverini, S., Albini, A. and Ferrari, N. (2008). Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-B and p53 modulation. Mol. Cancer Ther. 7, 2692-2702. DOI ScienceOn |
23 | Mun-Bryce, S. and Rosenberg, G. A. (1998). Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. J. Cerebral Blood Flow Metab. 18, 1163-1172. DOI |
24 | Pan, L., Becker, H. and Gerhäuser, C. (2005). Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol. Nutr. Food Res. 49, 837-843. DOI ScienceOn |
25 | Lee, Y. R. and Xia, L. (2007). ChemInform abstract: concise total synthesis of biologically interesting pyranochalcone natural products: citrunobin (Ia), boesenbergin A (Ib), boesenbergin B (IIa), xanthohumol C (IIb), and glabrachromene (IIc). Synthesis 20, 3240-3246. DOI ScienceOn |
26 | Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J. and Werb, Z. (1986). Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. The Journal of Biological Chemistry. 25, 2814-2818. |
27 | Miranda, C. L., Stevens, J. F., Ivanov, V., McCall, M., Frei, B., Deinzer, M. L. and Buhler, D. R. (2000b). Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem. 48, 3876-3884. DOI ScienceOn |
28 | Nikolic, D., Li, Y., Chadwick, L. R., Pauli, G. F. and van Breemen, R. B. (2005). Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J. Mass Spectrom. 40, 289-299. DOI ScienceOn |
29 | Gerhauser, C., Alt, A., Heiss, E., Gamal-Eldeen, A., Klimo, K., Knauft, J., Neumann, I., Scherf, H. R., Frank, N., Bartsch, H. and Becker, H. (2002). Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 1, 959-969. |
30 | Lee, K. S., Jin, S. M., Lee, H. and Lee, Y. C. (2004). Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma. Clin. Exp. Allergy. 34, 276-284. DOI |
31 | Liabakk, N. B., Talbot, I., Smith, R. A., Wilkinson, K. and Balkwill, F. (1996). Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56, 190-196. |
32 | Galis, Z. S., Sukhova, G. K., Lark, M. W. and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493-2503. DOI ScienceOn |
33 | Albini, A., Dell'Eva, R., Vené, R., Ferrari, N., Buhler, D. R., Noonan, D. M. and Fassina, G. (2006). Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J. 20, 527-529. DOI ScienceOn |
34 | Bernardo, M. M. and Fridman, R. (2003). TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase- 2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem. J. 374, 739-745. DOI ScienceOn |
35 | Delmulle, L., Bellahcéne, A., Dhooge, W., Comhaire, F., Roelens, F., Huvaere, K., Heyerick, A., Castronovo, V. and De Keukeleire, D. (2006). Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 13, 732-734. DOI ScienceOn |
36 | Edwards, J. G., McLaren, J., Jones, J. L., Waller, D. A. and O'Byrne, K. J. (2003). Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. Brit. J. Cancer 88, 1553-1559. DOI ScienceOn |